scholarly journals TCT-613 Natural History of Mitral Stenosis in Patients with Mitral Annular Calcification

2017 ◽  
Vol 70 (18) ◽  
pp. B253
Author(s):  
Rayji Tsutsui ◽  
Kinjal Banerjee ◽  
Samir Kapadia
Keyword(s):  
Natural History ◽  
Mitral Stenosis ◽  
Mitral Annular Calcification ◽  
History Of ◽  
Annular Calcification

scholarly journals Natural History of Mitral Stenosis in Patients With Mitral Annular Calcification

2019 ◽  
Vol 12 (6) ◽  
pp. 1105-1107 ◽  
Author(s):  
Rayji S. Tsutsui ◽  
Kinjal Banerjee ◽  
Samir Kapadia ◽  
James D. Thomas ◽  
Zoran B. Popović
Keyword(s):  
Natural History ◽  
Mitral Stenosis ◽  
Mitral Annular Calcification ◽  
History Of ◽  
Annular Calcification

Abstract 16851: Simultaneous Mitral Valve Replacement, Aortic Valve Replacement, Tricuspid Valve Repair, Left Atrial Appendage Ligation, Maze Procedure And Cabg In A 57-year Old Female With History Of Tavr And Severe Mitral Annular Calcification

Circulation ◽  
2021 ◽  
Vol 144 (Suppl_2) ◽  
Author(s):  
Hassan Mehmood Lak ◽  
Joshua Cohen ◽  
Jean Pierre Iskandar ◽  
Mohamed Gad ◽  
Sanchit Chawla ◽  
...  
Keyword(s):  
Aortic Valve ◽  
Aortic Valve Replacement ◽  
Valve Replacement ◽  
Tricuspid Regurgitation ◽  
Mitral Stenosis ◽  
Maze Procedure ◽  
Mitral Annular Calcification ◽  
Severe Tricuspid Regurgitation ◽  
History Of ◽  
Annular Calcification

Background: Open heart surgery is preferred for patients with multiple valvular issues with conflicting physiology. Case: A 57-year-old female with a past medical history of Type I Diabetes Mellitus complicated by kidney & pancreatic transplant in 1999 s/p failed kidney transplant in 2016 subsequently back on dialysis, aortic stenosis leading to Transcatheter Aortic Valve Replacement (TAVR) in 2016 who presented to the hospital for profound cardiogenic shock and was found to have severe tricuspid regurgitation, severe mitral stenosis secondary to mitral annular calcification with severe concentric hypertrophy of left ventricle. Decision Making: Her conflicting right and left heart physiology due to Tricuspid Regurgitation and Mitral Stenosis was very difficult to manage medically. She was not deemed a candidate for a heart transplant due to a history of a failed kidney transplant. She underwent surgery which included Mitral Valve Replacement, explant TAVR and repeat aortic valve replacement, Tricuspid repair, Left atrial appendage ligation and maze procedure, and CABG x1 with saphenous vein graft to PDA. She stayed on V-V extracorporeal membrane oxygenation (ECMO) post-operatively and was discharged on post-operative Day # 14. Conclusion: Severe tricuspid Regurgitation & coexisting mitral stenosis pose a dilemma for medical management and only feasible option is surgery which could be extremely challenging.

scholarly journals TCT-475 Natural History of Mitral Disease Associated With Mitral Annular Calcification

2021 ◽  
Vol 78 (19) ◽  
pp. B195
Author(s):  
Miho Fukui ◽  
Joao Cavalcante ◽  
Richard Bae ◽  
Vinayak Bapat ◽  
Mario Goessl ◽  
...  
Keyword(s):  
Natural History ◽  
Mitral Annular Calcification ◽  
History Of ◽  
Mitral Disease ◽  
Annular Calcification

scholarly journals TAVI in Patients with Mitral Annular Calcification and/or Mitral Stenosis

2020 ◽  
Author(s):  
Andreas Schaefer ◽  
Harun Sarwari ◽  
Niklas Schofer ◽  
Yvonne Schneeberger ◽  
Dirk Westermann ◽  
...  
Keyword(s):  
Mitral Stenosis ◽  
Cox Regression ◽  
Diastolic Pressure ◽  
Left Ventricular ◽  
Left Ventricular Ejection ◽  
Operating Characteristics ◽  
Mitral Annular Calcification ◽  
Ventricular Ejection Fraction ◽  
Transcatheter Aortic Valve ◽  
Annular Calcification

Abstract Background We herein aimed for analysis of influence of mitral annular calcification (MAC) and mitral stenosis (MS) on outcomes in transcatheter aortic valve implantation (TAVI). Methods Between 11/2009 and 06/2017, 1,058 patients underwent TAVI in the presence of concomitant MAC or MS at our center. Subgroups were built and multivariate logistic regression, COX regression, Kaplan–Meier survival analyses, and receiver operating characteristics method were performed. Results Thirty-day mortality was 7.5% (79/1,058) with highest mortality in patients severe MS (MAC: 3.4% vs. mild MS: 5.9% vs. moderate MS: 15.0% vs. severe MS: 72.7%; p < 0.001). Moderate-to-severe MS (odds ratio [OR]: 7.75, confidence interval [CI]: 3.94–16.26, p < 0.001), impaired left ventricular ejection fraction (OR: 1.38, CI: 1.10–1.72, p < 0.01), and coronary artery disease (OR: 1.36, CI: 1.11–1.67, p < 0.01) were predictive of 30-day survival. Left ventricular systolic/end-diastolic pressure drop of <59.5 mm Hg / <19.5 mm Hg was associated with increased mortality. Conclusions TAVI in the presence of MAC and mild MS is associated with acceptable acute outcomes but should be considered high-risk procedures in patients with moderate and especially those with severe MS. Our results suggest adverse hemodynamics after TAVI with concomitant MS, which may be caused by underfilling of the left ventricle leading to low-cardiac output.

Sign in / Sign up

Export Citation Format

Share Document